CUA Educational Content

Insights on Early Stage RCC Detection & Emerging Management Strategies

Recording from June 22, 2023

Speakers: Aly-Khan Lalani & Simon Tanguay


  • Recognize early RCC disease stage symptoms and underlying risk factors associated with recurrence rates
  • Assess emergent adjuvant RCC clinical trial data and their impact on current clinical practice
  • Identify key patient factors important for the consideration of adjuvant therapy in early stage RCC


This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.


This program has received financial support from AstraZeneca / Merck in the form of an educational grant.